ATE542885T1 - Impfungs-ausführungsarten - Google Patents

Impfungs-ausführungsarten

Info

Publication number
ATE542885T1
ATE542885T1 AT99912985T AT99912985T ATE542885T1 AT E542885 T1 ATE542885 T1 AT E542885T1 AT 99912985 T AT99912985 T AT 99912985T AT 99912985 T AT99912985 T AT 99912985T AT E542885 T1 ATE542885 T1 AT E542885T1
Authority
AT
Austria
Prior art keywords
ari
sub
vaccination
necatrix
performance types
Prior art date
Application number
AT99912985T
Other languages
English (en)
Inventor
David Richards
Wayne Jorgensen
Norman Stewart
Original Assignee
Eimeria Pty Ltd
State Of Queensland Through The Dept Of Primary Ind
Rural Ind Res And Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eimeria Pty Ltd, State Of Queensland Through The Dept Of Primary Ind, Rural Ind Res And Dev Corp filed Critical Eimeria Pty Ltd
Application granted granted Critical
Publication of ATE542885T1 publication Critical patent/ATE542885T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99912985T 1998-03-30 1999-03-30 Impfungs-ausführungsarten ATE542885T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP2683A AUPP268398A0 (en) 1998-03-30 1998-03-30 Vaccination modalitites
PCT/AU1999/000232 WO1999050387A1 (en) 1998-03-30 1999-03-30 Vaccination modalities

Publications (1)

Publication Number Publication Date
ATE542885T1 true ATE542885T1 (de) 2012-02-15

Family

ID=3806944

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99912985T ATE542885T1 (de) 1998-03-30 1999-03-30 Impfungs-ausführungsarten

Country Status (7)

Country Link
US (1) US7211265B2 (de)
EP (1) EP1068293B1 (de)
JP (1) JP4549530B2 (de)
AT (1) ATE542885T1 (de)
AU (1) AUPP268398A0 (de)
ES (1) ES2383429T3 (de)
WO (1) WO1999050387A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
EP2296698A1 (de) 2008-05-29 2011-03-23 Intervet International BV Kokzidiose-impfstoffe
BRPI0921843B1 (pt) 2008-11-13 2020-11-24 Intervet International B.V. composição de vacina, e, uso de uma composição de vacina
JP2021531262A (ja) * 2018-07-10 2021-11-18 アプライド ライフサイエンシズ アンド システムズ エルエルシー ゲルを準備及び送達するシステム及び方法
WO2023170057A1 (en) 2022-03-08 2023-09-14 Hipra Scientific, S.L.U. In ovo vaccine compositions against coccidiosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
DE3785404T2 (de) * 1986-08-18 1993-07-29 British Tech Group Impfstoffe.
AU5989894A (en) * 1993-01-19 1994-08-15 Merck & Co., Inc. Live coccidiosis vaccine

Also Published As

Publication number Publication date
JP4549530B2 (ja) 2010-09-22
US20050008659A1 (en) 2005-01-13
AUPP268398A0 (en) 1998-04-23
JP2002509941A (ja) 2002-04-02
ES2383429T3 (es) 2012-06-21
US7211265B2 (en) 2007-05-01
EP1068293B1 (de) 2012-01-25
EP1068293A4 (de) 2004-12-22
WO1999050387A1 (en) 1999-10-07
EP1068293A1 (de) 2001-01-17

Similar Documents

Publication Publication Date Title
DE60210456D1 (de) Solubisierung von kapseln polysacchariden
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
EE05633B1 (et) Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine
ZA88798B (en) Dental anti-plaque and anti-caries agent
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
TW429150B (en) In ovo vaccine against coccidiosis
WO2004000859A3 (en) Etoposide analogs and methods of use thereof
NZ510369A (en) Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
UA87815C2 (ru) Иммуногенная или вакцинная композиция для защиты от кокцидиоза и способ индуцирования иммунного ответа у цыплят
DK1237549T3 (da) Lipoxin A4 og dets analoger til behandling af törre öjne
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
DE69732709D1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
ATE143369T1 (de) Überbrückte, cyclische ketale
DE60226175D1 (de) Mycobakterieller impfstoff
ATE542885T1 (de) Impfungs-ausführungsarten
CY1105345T1 (el) Φαινυλαλκινια
EA200100700A1 (ru) Гены и белки и их применение
WO2003039592A3 (de) Zelluläre impfstoffe mit adjuvanzien
BR9803232A (pt) Vaicna de neospora.
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
BR0009077A (pt) Antìgenos de tuberculose e métodos de uso dos mesmos
PL337576A1 (en) Method of searching for compounds being useful in preventing infections and pathogenic effects